Motus Therapeutics

About:

Motus Therapeutics is a biotechnology company developing peptide therapeutics for the treatment of metabolic diseases.

Top Investors: New Enterprise Associates, Ipsen, Michael J. Fox Foundation, Pfizer Venture Investments, Third Rock Ventures

Description:

Motus Therapeutics is a biotechnology company developing peptide therapeutics that address unmet needs in metabolic diseases. Rhythm investors include MPM Capital and New Enterprise Associates. The company is based in Boston, Massachusetts.

Total Funding Amount:

$95.9M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2008-01-01

Contact Email:

info(AT)motustx.com

Founders:

Bart Henderson, Elizabeth Stoner

Number of Employees:

11-50

Last Funding Date:

2015-09-24

IPO Status:

Private

Industries: